In the May 2013 news analysis “Second oral MS drug...” (Nat. Biotechnol. 31, 373, 2013), the headline incorrectly stated that the drug Tecfidera was the second oral MS drug to win FDA approval when it was the third. The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nbt0513-373a
Rights and permissions
About this article
Cite this article
Correction. Nat Biotechnol 31, 867 (2013). https://doi.org/10.1038/nbt1013-867b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1013-867b
